Gvoke HypoPen 2-Pack™ Now Available!

The first autoinjector for severe hypoglycemia1

Gvoke HypoPen™ (glucagon injection)

For the treatment of severe hypoglycemia in adult and pediatric patients with diabetes ages 2 and above.2

For more information, including how to access Gvoke,
please contact Xeris Medical Team at:
1‑877‑XERIS37 (1‑877‑937‑4737)

Gvoke is not approved outside of the U.S.

It's premixed and ready-to-go3

Why Prescribe Gvoke

Reliable Method of Delivery

A subcutaneous injection that 99% of people were able to give correctly in usability studies2,4

Why Prescribe Gvoke

Proven to Work

99% of adult and 100% of pediatric patients had their blood glucose raised to safe levels2

See the Efficacy

Financial support and access
Financial Support and Access

Financial support is available to qualifying patients through the myGvoke™ program

View myGvoke Offers

References: 1. U.S. Food and Drug Administration. Search results for “glucagon.” Drugs@FDA: FDA approved drug products. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process.Access September 13, 2019. 2. Gvoke [prescribing information], Chicago, IL; Xeris Pharmaceuticals, Inc. 3. Gvoke HypoPen [instructions for use], Chicago, IL: Xeris Pharmaceuticals, Inc. 4. Newswanger B, Prestreleski S, Andre AD. Human factor studies of a prefilled syringe with stable liquid glucagon in a simulated severe hypoglycemia rescue situation. Expert Opin Drug Deliv. 2019;16(9):1015-1025.